BIIB
USDBiogen Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$129.550
उच्च
$129.580
कम
$124.680
मात्रा
1.14M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
18.3B
उद्योग
Drug Manufacturers - General
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
1.48M
एक्सचेंज
NMS
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
Global Phase 3 PROMINENT study will evaluate the efficacy and safety of felzartamab, as compared to tacrolimus, in adults with primary membranous nephropathy (PMN)There are currently no therapies specifically approved
New Data for Nusinersen Underscore Biogen's Commitment to Advancing Clinical Research to Improve Outcomes in SMA
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SPINRAZA®
RBC Capital Reiterates Outperform on Biogen, Maintains $213 Price Target
RBC Capital analyst Brian Abrahams reiterates Biogen with a Outperform and maintains $213 price target.
HC Wainwright & Co. Reiterates Buy on Biogen, Maintains $187 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Biogen with a Buy and maintains $187 price target.
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in spinal muscular atrophy (SMA)Interim Phase 1 data show children with SMA
Piper Sandler Reiterates Neutral on Biogen, Maintains $115 Price Target
Piper Sandler analyst David Amsellem reiterates Biogen with a Neutral and maintains $115 price target.
Wedbush Reiterates Neutral on Biogen, Maintains $121 Price Target
Wedbush analyst Laura Chico reiterates Biogen with a Neutral and maintains $121 price target.
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।